Trial intelligence / Profile preview

2-Iminobiotin in Neonates with Perinatal Asphyxia

NCT01626924Phase 2Terminated

Sponsor
Neurophyxia
Start
Jun 2012
Primary completion
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of 2-iminobiotin in perinatal asphyxia, sponsored by Neurophyxia. Started Jun 2012; status: terminated.

02

Drugs

2-iminobiotin
03

Conditions

perinatal asphyxia

Beyond the preview

Go deeper on NCT01626924.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01626924.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call